TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non-Small-Cell Lung Cancer: AF-001JP.

Tomohide Tamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.